Sensible Biotechnologies (Biotechnology) — Funding, Investors & Signals 2026

Sensible Biotechnologies

Unlocking the next generation of mRNA medicines.

Founded 2021 26 employees Pre Seed Total: $4.20M Biotechnology

Sensible Biotechnologies is a biotechnology startup with a mission to unlock the next generation of mRNA medicines. Founded in 2021, the company's slogan, "Unlocking the next generation of mRNA medicines," captures its dedication to innovation in the biotech space. Sensible Biotechnologies is focused on building a best-in-class platform for manufacturing high-quality mRNA in a scalable manner, aiming to revolutionize the development of mRNA medicines while enhancing global biosecurity. The company recently secured a significant $4.20M Pre Seed Round investment on 06 April 2023. Noteworthy investors participating in this latest round include Blue Yard Capital, Y Combinator, Civilization Ventures, Possible Ventures, ZAKA VC, Springboard Health Angels, Recode Health Ventures, Amino Collective, Jason C. Foster, and Florian Schuster. This investment demonstrates the confidence that these prominent investors have in Sensible Biotechnologies' vision and capabilities. Sensible Biotechnologies has positioned itself at the forefront of mRNA medicine development, and with this recent investment, the company is poised to make significant strides in realizing its objectives.

Funding Stage	Amount	Investors	Lead Investors	Date
Pre Seed Round	••••••	10	•••• ••••	06 Apr 2023
Funding Round	••••••	-		21 Feb 2023
Pre Seed Round	••••••	-		17 Mar 2022

Funding Stage

Amount

Investors

Lead Investors

Date

Pre Seed Round

••••••

•••• ••••

06 Apr 2023

Funding Round

••••••

21 Feb 2023

Pre Seed Round

••••••

17 Mar 2022

FAQ About Sensible Biotechnologies

Unlocking the next generation of mRNA medicines.

Sensible Biotechnologies was founded in 2021.

Sensible Biotechnologies operates in the following industries: Biotechnology.

Sensible Biotechnologies has approximately 26 employees.

Sensible Biotechnologies has completed 3 funding rounds, raising a total of $4.20M. The latest funding stage is Pre Seed.

Top alternatives and competitors to Sensible Biotechnologies include Providence Therapeutics, RNAimmune, mCureX Therapeutics, Inc., CureVac, Strand Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Sensible Biotechnologies and Providence Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Sensible Biotechnologies

General Information

Track Sensible Biotechnologies

Discover More

About Sensible Biotechnologies

Funding Rounds & Investors (3)

Latest News

Sensible Biotechnologies Alternatives & Competitors

FAQ About Sensible Biotechnologies

Don't just browse. Track.